STERIS
STE
STERIS (STE) earnings history
Most recent quarter
- Fiscal period
- Q1 2027
- Period end
- Jun 30, 2026
- EPS actual
- $2.59
- EPS estimate
- $2.49
- EPS surprise
- +3.82%
- Revenue surprise
- +0.34%
- Revenue
- $1.5B
- Revenue estimate
- $1.5B
- Reported
- Aug 5, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2027 | Aug 5, 2026 | $2.49 | $2.59 | +3.82% | $1.5B | SEC |
| Q4 2026 | May 11, 2026 | $2.85 | $2.83 | −0.65% | $1.6B | SEC |
| Q3 2026 | Feb 4, 2026 | $2.53 | $2.53 | −0.10% | $1.5B | SEC |
| Q2 2026 | Nov 5, 2025 | $2.35 | $2.47 | +5.05% | $1.5B | SEC |
| Q1 2026 | Aug 6, 2025 | $2.26 | $2.34 | +3.37% | $1.4B | SEC |
| Q4 2025 | May 14, 2025 | $2.60 | $2.74 | +5.44% | $1.5B | SEC |
| Q3 2025 | Feb 5, 2025 | $2.32 | $2.32 | −0.06% | $1.4B | SEC |
| Q2 2025 | Nov 6, 2024 | $2.12 | $2.14 | +0.81% | $1.3B | SEC |
| Q1 2025 | Aug 6, 2024 | $1.98 | $2.14 | +8.24% | $1.3B | SEC |
| Q4 2024 | May 8, 2024 | $2.35 | $2.41 | +2.55% | $1.4B | SEC |
| Q3 2024 | Feb 7, 2024 | $2.17 | $2.22 | +2.37% | $1.4B | SEC |
| Q2 2024 | Nov 7, 2023 | $2.00 | $2.03 | +1.33% | $1.3B | SEC |
| Q1 2024 | Aug 1, 2023 | $1.86 | $2.00 | +7.53% | $1.3B | SEC |
| Q4 2023 | May 10, 2023 | $2.15 | $2.30 | +7.06% | $1.4B | SEC |
| Q3 2023 | Feb 8, 2023 | $2.19 | $2.02 | −7.90% | $1.2B | SEC |
| Q2 2023 | Nov 9, 2022 | $1.98 | $1.99 | +0.34% | $1.2B | SEC |
| Q1 2023 | Aug 2, 2022 | $1.92 | $1.90 | −0.78% | $1.2B | SEC |
| Q4 2022 | May 12, 2022 | $2.02 | $2.04 | +0.89% | $1.2B | SEC |
| Q3 2022 | Feb 8, 2022 | $1.96 | $2.12 | +8.05% | $1.2B | SEC |
| Q2 2022 | Nov 2, 2021 | $1.82 | $1.99 | +9.34% | $1.2B | SEC |
Quarterly revenue
Frequently asked questions
When did STERIS (STE) last report earnings?
STERIS last reported on Aug 5, 2026, covering fiscal Q1 2027.
Did STE beat earnings estimates?
Yes. STERIS reported EPS of $2.59 for Q1 2027 against a $2.49 estimate — a 3.82% beat.
How much revenue did STE report last quarter?
STERIS reported $1.5B in revenue for Q1 2027, against a consensus estimate of $1.5B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.